A. David Rodrigues

3.7k citations

68 papers · 3.0k indexed · h-index 33

Pharmacology top 0.05%
Oncology top 2%
Molecular Biology
Pharmacology top 2%
Pediatrics, Perinatology and Child Health top 5%

Co-authors: Magang Shou Gondi Kumar Thomas H. Rushmore Alex Buko Jon F. Denissen Costas Ioannides Wenying Li Cuyue Tang
Topics: Pharmacogenetics and Drug Metabolism (41 papers)Drug Transport and Resistance Mechanisms (24 papers)Inflammatory mediators and NSAID effects (9 papers)
Cited by: Pharmacology Biochemistry Oncology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaAnalytical Biochemistry
Partner nations: United States United Kingdom Brazil

In The Last Decade

A. David Rodrigues

68 papers receiving 2.9k citations

Peers

Countries citing papers authored by A. David Rodrigues

Since Specialization

Citations

This map shows the geographic impact of A. David Rodrigues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. David Rodrigues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. David Rodrigues more than expected).

Fields of papers citing papers by A. David Rodrigues

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. David Rodrigues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. David Rodrigues. The network helps show where A. David Rodrigues may publish in the future.

Co-authorship network of co-authors of A. David Rodrigues

This figure shows the co-authorship network connecting the top 25 collaborators of A. David Rodrigues. A scholar is included among the top collaborators of A. David Rodrigues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. David Rodrigues. A. David Rodrigues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cyclosporine A sterically inhibits statin transport by solute carrier OATP1B1 2025 ·Journal of Biological Chemistry ·Min Woo Sung,(unknown),Lea M. Hürlimann,Joshua A. Lees,Kimberly F. Fennell,Mark A. West,Chester Costales,A. David Rodrigues,Iwan Zimmermann,Roger Dawson,Shenping Liu,Seungil Han	2
2	Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7) 2020 ·Biochemical Pharmacology ·Sumathy Mathialagan,Yi‐An Bi,Chester Costales,Amit S. Kalgutkar,A. David Rodrigues,Manthena V. S. Varma	31
3	Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Yi‐An Bi,Chester Costales,Sumathy Mathialagan,Mark A. West,(unknown),Sarah Lazzaro,Laurie Tylaska,Renato J. Scialis,Hui Zhang,John P. Umland,Emi Kimoto,David A. Tess,Bo Feng,Larry M. Tremaine,Manthena V. S. Varma,A. David Rodrigues	66
4	Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation 2018 ·Drug Metabolism and Disposition ·Anna Vildhede,Chuong Nguyen,Brian K. Erickson,Ryan C. Kunz,Richard C. Jones,Emi Kimoto,Francis Bourbonais,A. David Rodrigues,Manthena V. S. Varma	26
5	Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Yi‐An Bi,Sumathy Mathialagan,Laurie Tylaska,(unknown),(unknown),Anna Vildhede,Chester Costales,A. David Rodrigues,Manthena V. S. Varma	32
6	Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes 2017 ·The AAPS Journal ·Yi‐An Bi,Renato J. Scialis,Sarah Lazzaro,Sumathy Mathialagan,Emi Kimoto,(unknown),Hui Zhang,Anna Vildhede,Chester Costales,A. David Rodrigues,Larry M. Tremaine,Manthena V. S. Varma	39
7	Organic Anion Transporter 2: An Enigmatic Human Solute Carrier 2016 ·Drug Metabolism and Disposition ·Hong Shen,Yurong Lai,A. David Rodrigues	68
8	Hydrogen sulfide donors alleviate itch secondary to the activation of type-2 protease activated receptors (PAR-2) in mice 2016 ·Pharmacological Research ·(unknown),A. David Rodrigues,Simone A. Teixeira,António G. Soares,Roberta Torregrossa,Mark E. Wood,Matthew Whiteman,Soraia K.P. Costa,Marcelo N. Muscará	16
9	Studies to Further Investigate the Inhibition of Human Liver Microsomal CYP2C8 by the Acyl-β-Glucuronide of Gemfibrozil 2011 ·Drug Metabolism and Disposition ·S. M. Jenkins,Tatyana Zvyaga,(unknown),(unknown),Andrew J. Wagner,Richard C. Burrell,(unknown),John E. Leet,(unknown),A. David Rodrigues	25
10	Repaglinide‐gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism 2010 ·British Journal of Clinical Pharmacology ·Jinping Gan,Weiqi Chen,Hong Shen,Ling Gao,(unknown),Yuan Tian,Wenying Li,Yueping Zhang,(unknown),Hongjian Zhang,W. Griffith Humphreys,A. David Rodrigues	34
11	Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro 2008 ·Drug Metabolism and Disposition ·Shu‐Ying Chang,Wenying Li,Sarah C. Traeger,Bei Wang,Donghui Cui,Hongjian Zhang,Bo Wen,A. David Rodrigues	53
12	Troglitazone Thiol Adduct Formation in Human Liver Microsomes: Enzyme Knietics and Reaction Phenotyping 2008 ·Drug Metabolism Letters ·Jinping Gan,(unknown),Bing He,Wen Chyi Shyu,A. David Rodrigues,Kan He	2
13	MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR 2003 ·Drug Metabolism and Disposition ·Ping Lü,Michael Schrag,Donald E. Slaughter,Conrad E. Raab,Magang Shou,A. David Rodrigues	86
14	Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001). 1997 ·PubMed ·Gondi Kumar,(unknown),A. David Rodrigues,Ellen Roberts,(unknown)	17
15	Enhanced decomposition of oxyferrous cytochrome P450CIA1 (P450cam) by the chemopreventive agent 3-t-butyl-4-hydroxyanisole 1990 ·Archives of Biochemistry and Biophysics ·S.D. Gettings,Colleen B. Brewer,William M. Pierce,Julian A. Peterson,A. David Rodrigues,Russell A. Prough	3
16	Adverse reactions of imidazole antifungal agents: Computer graphic studies of cytochrome P‐450 interactions 1989 ·Journal of Biochemical Toxicology ·D. F. V. Lewis,A. David Rodrigues,Costas Ioannides,D. V. Parke	11
17	The food pyrolysis product IQ enhances its own activation 1989 ·Mutagenesis ·Andrew D. Ayrton,E. J. Williams,A. David Rodrigues,Costas Ioannides,Rheeda L. Walker	8
18	Preferential induction of the rat hepatic P450 I proteins by the food carcinogen 2‐amino‐3‐methyl‐imidazo[4,5‐f]quinoline 1989 ·European Journal of Biochemistry ·A. David Rodrigues,Andrew D. Ayrton,(unknown),D. F. V. Lewis,Ronald W. Walker,Costas Ioannides	11
19	Induction of the rat hepatic microsomal mixed-function oxidases by 3 imidazole-containing antifungal agents: selectivity for the cytochrome P-450IIB and P-450III families of cytochromes P-450 1988 ·Toxicology ·A. David Rodrigues,(unknown),Eric Ah-Sing,B. A. Morris,C. Roland Wolf,Costas Ioannides	42
20	Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins 1987 ·Biochemical Pharmacology ·A. David Rodrigues,G. Gordon Gibson,Costas Ioannides,D. V. Parke	111

About A. David Rodrigues

A. David Rodrigues is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 68 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (24 papers) and Inflammatory mediators and NSAID effects (9 papers). The work is most often cited by research in Pharmacology (1.8k citations), Biochemistry (330 citations) and Oncology (1.1k citations). A. David Rodrigues has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Magang Shou, Gondi Kumar, Thomas H. Rushmore, Alex Buko, Jon F. Denissen, Costas Ioannides, Wenying Li, Cuyue Tang, Ellen Roberts and Donglu Zhang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact